Hardeep Uppal
Neurology · Jackson, MSNPI 1295295681
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 102 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by ANI Pharmaceuticals, Inc. at 36.7% of the total. 2025 is the largest year on record at $1,711, 5.3 times the $323 reported in 2022.
Across 102 payments — averaging $36.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ANI Pharmaceuticals, Inc.$1K
- Acadia Pharmaceuticals Inc$269
- AstraZeneca$239
- AbbVie$226
- UCB, Inc.$170
- Takeda Pharmaceuticals U.S.A., Inc.$156
- plus $1K from 23 others
What the payments were for
- Food & beverage$3,732100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 14 | $1,369 |
| Acadia Pharmaceuticals Inc | 12 | $269 |
| AstraZeneca(2 entities) | 10 | $239 |
| AbbVie(2 entities) | 3 | $226 |
| UCB, Inc. | 8 | $170 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $156 |
| Argenx US, Inc. | 6 | $141 |
| SK Life Science, Inc. | 6 | $137 |
| Microtransponder, Inc. | 1 | $136 |
| Lilly USA, LLC | 8 | $126 |
| TG Therapeutics, Inc. | 1 | $123 |
| Lundbeck LLC | 5 | $108 |
| Biogen | 4 | $102 |
| Alnylam Pharmaceuticals Inc. | 3 | $48 |
| Mallinckrodt Hospital Products Inc. | 2 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| Jazz Pharmaceuticals Inc. | 2 | $45 |
| Medtronic | 1 | $27 |
| Penumbra, Inc. | 1 | $27 |
| Merz Pharmaceuticals, LLC | 1 | $23 |
| Catalyst Pharmaceuticals, Inc. | 1 | $23 |
| Eisai Inc. | 1 | $23 |
| MDD US Operations, LLC | 1 | $22 |
| Ceribell, Inc. | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Amneal Pharmaceuticals LLC | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PURIFIED CORTROPHIN GEL$1,136
- BRIUMVI$123
- GAMMAGARD LIQUID$118
- BOTOX$109
How this compares
$3,732 in reported general payments places this provider in the 55th percentile of 111 neurology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Jackson
- Ruth FredericksJackson$943K
- Wendell HelvestonJackson$883K
- Rajesh SharmaJackson$152K
- Patrick WeldonJackson$85K
- Riichi OtaJackson$53K
- Mitchell MyersJackson$43K
- Tiffany ScarffJackson$29K
- Derek LetortJackson$25K
- Shreyas GangadharaJackson$20K
- Juebin HuangJackson$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.